Retinal Diagnostics in Alzheimer Disease: Where Are We Now?

Here’s how imaging is helping pave the path forward.

Dilraj S. Grewal, MD, FASRS, and Sharon Fekrat, MD, FASRS

The Challenge of IRD in Children

Researchers are investigating ways to tackle delayed diagnosis, imaging complications, and unreliable access to genetic testing in pediatric care.

Angela S. Li, MD; Cesar Estrada-Puente, MD; Paula C. Morales, MD; and Ramiro Maldonado, MD

PBM for AMD: Mechanisms, Evidence, and Clinical Integration

Photobiomodulation shows promise, but long-term data are needed.

Luis Acabá-Berrocal, MD, and Anton Orlin, MD

Using E/M and Eye Visit Codes When Surgical Reimbursement Declines

These strategies can help you determine which code to use.

Matthew Baugh, MHA, COT, OCS, OCSR

Vigabatrin-Related Retinal Toxicity

Patients taking this medication for epilepsy should be monitored carefully for visual disturbances.

Natalia Londoño De Vivero, MD; Rafael Méndez Marulanda, MD; Daniela Rojas Pérez, MD; Clemencia De Vivero Arciniegas, MD; and Álvaro Mejía Vergara, MD